US 11,786,729 B2
Systems and methods for enhancing or affecting neural stimulation efficiency and/or efficacy
Bradford Evan Gliner, Sammamish, WA (US); Allen Wyler, Seattle, WA (US); Brad Fowler, Woodinville, WA (US); W. Douglas Sheffield, Seatac, WA (US); Richard Kuntz, Lakebay, WA (US); Kent Leyde, Redmond, WA (US); and Leif R. Sloan, Seattle, WA (US)
Assigned to Advanced Neuromodulation Systems, Inc., Plano, TX (US)
Filed by Advanced Neuromodulation Systems, Inc., Plano, TX (US)
Filed on Jun. 15, 2021, as Appl. No. 17/347,865.
Application 12/327,711 is a division of application No. 11/182,713, filed on Jul. 15, 2005, granted, now 7,483,747, issued on Jan. 27, 2009.
Application 17/347,865 is a continuation of application No. 15/805,052, filed on Nov. 6, 2017, granted, now 11,065,449.
Application 15/805,052 is a continuation of application No. 14/942,800, filed on Nov. 16, 2015, granted, now 9,808,627, issued on Nov. 7, 2017.
Application 14/942,800 is a continuation of application No. 14/101,189, filed on Dec. 9, 2013, granted, now 9,186,510, issued on Nov. 17, 2015.
Application 14/101,189 is a continuation of application No. 13/179,133, filed on Jul. 8, 2011, granted, now 8,606,361, issued on Dec. 10, 2013.
Application 13/179,133 is a continuation of application No. 12/327,711, filed on Dec. 3, 2008, granted, now 7,983,762, issued on Jul. 19, 2011.
Claims priority of provisional application 60/588,406, filed on Jul. 15, 2004.
Prior Publication US 2021/0308456 A1, Oct. 7, 2021
This patent is subject to a terminal disclaimer.
Int. Cl. A61N 1/36 (2006.01); A61N 1/08 (2006.01); H04L 67/565 (2022.01); H04L 67/568 (2022.01); G06F 13/38 (2006.01); H04L 49/90 (2022.01); H04L 49/901 (2022.01); A61N 1/05 (2006.01); A61N 1/372 (2006.01)
CPC A61N 1/3606 (2013.01) [A61N 1/36135 (2013.01); A61N 1/36146 (2013.01); G06F 13/385 (2013.01); H04L 49/90 (2013.01); H04L 49/901 (2013.01); H04L 67/565 (2022.05); H04L 67/568 (2022.05); A61N 1/0531 (2013.01); A61N 1/0534 (2013.01); A61N 1/36064 (2013.01); A61N 1/36067 (2013.01); A61N 1/36082 (2013.01); A61N 1/36103 (2013.01); A61N 1/37252 (2013.01); Y02D 10/00 (2018.01)] 20 Claims
OG exemplary drawing
 
1. A method of treating chronic pain in a patient using spinal cord stimulation (SCS), comprising:
establishing a wireless communication session, using a controller device, with an implantable pulse generator (IPG) that is adapted to generate electrical stimulation for application to neural tissue of the patient according to programmed therapy parameters, wherein the IPG comprises a header structure connected to one or more implantable stimulation leads with one or more electrodes placed in an epidural space of the patient for stimulation of spinal cord fibers of the patient; and
programming therapy parameters for SCS for the patient during the wireless communication session by communicating the programmed therapy parameters from the controller device to the IPG, wherein the controller device is configured to control the IPG to direct an application of electrical stimulation to the patient in a manner such that the electrical stimulation has a burst frequency and an intra-burst frequency greater than the burst frequency, wherein the controller device directs application of the electrical stimulation according to a duty cycle with stimulation-on periods where electrical stimulation is applied with intervening stimulation-off periods where electrical stimulation is temporarily halted between respective stimulation on-periods, and wherein the duty cycle stimulation-on periods and stimulation-off periods are controlled by a programmable duty cycle parameter set by communication with the controller device.